+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
JUBLINGREA

Jubilant Ingrevia Share Price

₹586.40 -45.95 (-7.27%)
26.24% Fall from 52W High

28 Oct, 2026 12:18 PM (IST)

Jubilant Ingrevia live price: ₹586.40. It opened at ₹640 vs previous close ₹632; intraday high/low: ₹642/₹581. The 50 & 200 DMA stand at ₹650.30/₹671.00.

Jubilant Ingrevia Performance

  • Today's Low
  • ₹581
  • Today's High
  • ₹642
  • 52 Week Low
  • ₹537
  • 52 Week High
  • ₹795
  • Open Price₹640
  • Previous Close₹632
  • Volume2,480,621
  • 50 DMA₹650.30
  • 100 DMA₹664.40
  • 200 DMA₹671.00

Jubilant Ingrevia Chart

Investment Returns

  • Over 1 Month -10.62%
  • Over 3 Month -21.19%
  • Over 6 Month -20.17%
  • Over 1 Year -13.41%

Smart Investing Starts Here Start SIP with Jubilant Ingrevia for Steady Growth!

Invest Now

Jubilant Ingrevia Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 26.6
  • PEG Ratio
  • 1.2
  • Market Cap Cr
  • 9,340
  • P/B Ratio
  • 2.9
  • Average True Range
  • 22.7
  • EPS
  • 22
  • Dividend Yield
  • 0.9
  • MACD Signal
  • -11.9
  • RSI
  • 49.47
  • MFI
  • 61.69

Latest Stock News Updates

Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulations 30 of the SEBI Listing Regulations, we wish to inform that audio recording of investors' Conference Call for un-audited financial results for the quarter and half year ended September 30, 2026, held on Tuesday, October 27, 2026 has been uploaded on the Company's website.

Jubilant Ingrevia Q2 net profit surges 60% to 111 cr

The company had posted a consolidated net profit of 69.47 crore in the corresponding quarter of the preceding fiscal

Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release & Investor Presentation

Jubilant Ingrevia Financials

Jubilant Ingrevia Technicals

EMA & SMA

Current Price
₹586.40
-45.95 (-7.27%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹627.70
  • 50 Day
  • ₹650.30
  • 100 Day
  • ₹664.40
  • 200 Day
  • ₹671.00

Resistance and Support

603.27 Pivot Speed
  • R3 713.90
  • R2 686.20
  • R1 659.20
  • S1 604.60
  • S2 576.80
  • S3 550.00

Jubilant Ingrevia Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-27 Quarterly Results
2026-07-22 Quarterly Results
2026-05-26 Audited Results & Final Dividend
2026-02-04 Quarterly Results
2025-10-27 Quarterly Results
Date Purpose Remarks
2026-07-24 FINAL Rs.2.50 per share(250%)Final Dividend
2026-02-10 INTERIM Rs.2.50 per share(250%)Interim Dividend
2025-07-25 FINAL Rs.2.50 per share(250%)Final Dividend
2025-02-03 INTERIM Rs.2.50 per share(250%)Interim Dividend
2024-08-02 FINAL Rs.2.50 per share(250%)Final Dividend
View Jubilant Ingrevia Dividend History Arrow

Jubilant Ingrevia Shareholding Pattern

45.22%
22.59%
21.69%
6.93%
2.61%

About Jubilant Ingrevia

Jubilant Ingrevia is engaged in manufacturing and supply of speciality chemicals, nutrition and health solutions and chemical intermediates through five manufacturing facilities in India. View More
  • NSE Symbol
  • JUBLINGREA
  • BSE Symbol
  • 543271
  • Executive Director,Managing Director,Chief Executive Officer
  • Mr. Deepak Jain
  • ISIN
  • INE0BY001018

Similar Stocks to Jubilant Ingrevia

Jubilant Ingrevia FAQs

Jubilant Ingrevia share price is ₹586 As on 28 October, 2026 | 12:08

The Market Cap of Jubilant Ingrevia is ₹9340.2 Cr As on 28 October, 2026 | 12:08

The P/E ratio of Jubilant Ingrevia is 26.6 As on 28 October, 2026 | 12:08

The PB ratio of Jubilant Ingrevia is 2.9 As on 28 October, 2026 | 12:08

The 52 week High & Low of Jubilant Ingrevia is ₹795/₹537.3 respectively As on 28 October, 2026 | 12:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23